Access Resources
4121 - 4130 of 7540 Results
Title
Year
-
RESTRICTEDTitle: Choosing a Parkinson Disease TreatmentJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 323Issue #: 14Start Page: 1420End Page: 1420Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2020.1224Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2764458/jama_armstrong_2020_pg_200005.pdfCitation Count: 20
-
RESTRICTEDTitle: Clinicopathologic and genetic features of multiple system atrophy with Lewy body diseaseJournal Name: Brain PathologyPublisher: WileyVol: 30Issue #: 4Start Page: 766End Page: 778Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1111/bpa.12839Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bpa.12839Citation Count: 19
- Contingent negative variation: a biomarker of abnormal attention in functional movement disorders2020RESTRICTEDTitle: Contingent negative variation: a biomarker of abnormal attention in functional movement disordersJournal Name: European Journal of NeurologyPublisher: WileyVol: 27Issue #: 6Start Page: 985End Page: 994Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/ene.14189Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.14189Citation Count: 10
-
RESTRICTEDTitle: Modeling PD Progression in the PPMI Cohort: Implications for Clinical Trial Design (4402)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4402Citation Count: 0
- Nilotinib Fails to Prevent Synucleinopathy and Cell Loss in a Mouse Model of Multiple System Atrophy2020RESTRICTEDTitle: Nilotinib Fails to Prevent Synucleinopathy and Cell Loss in a Mouse Model of Multiple System AtrophyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 7Start Page: 1163End Page: 1172Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28034Citation Count: 12
- Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)2020RESTRICTEDTitle: Pharmacokinetics and Biomarker Changes in NILO-PD, A Phase 2A Study of Nilotinib in Patients with Moderate to Advance Parkinson’s Disease (4418)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4418Citation Count: 0
-
RESTRICTEDTitle: PPMI 2.O New Science/New Cohorts - Transforming PPMI (2490)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.2490Citation Count: 0
-
-
RESTRICTEDTitle: Validation of Fox Insight Cohort via Virtual Research Visits (4749)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4749Citation Count: 0
- A Comprehensive Review of Brain Connectomics and Imaging to Improve Deep Brain Stimulation Outcomes2020RESTRICTEDTitle: A Comprehensive Review of Brain Connectomics and Imaging to Improve Deep Brain Stimulation OutcomesJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 741End Page: 751Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28045Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556988Citation Count: 39